Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of ascending single oral doses of SAM-315, an
investigational drug, in healthy Japanese male subjects.To obtain preliminary pharmacokinetic
(PK) and pharmacodynamic (PD) profiles of SAM-315 in healthy Japanese male subjects.